Kratom at a crossroads: Trends, controversies, and the evidence gap
Cleveland Clinic Journal of Medicine · 2026-08 · 93 (8) · 487-492
DOI: 10.3949/ccjm.93a.25088 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cleveland Clinic Journal of Medicine, online erschienen am 03.08.2026. Verfasst von Vania Modesto-Lowe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Adjunct Professor, School of Health Sciences, Quinnipiac University, Hamden, CT. Hauptthemen laut MEDLINE: Mitragyna, Substance-Related Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Adjunct Professor, School of Health Sciences, Quinnipiac University, Hamden, CT.
- Adjunct Professor, School of Health Sciences, Quinnipiac University, Hamden, CT deanna.sgambato@quinnipiac.edu.
- Principal Psychiatrist, Department of Mental Health and Addiction Services, Connecticut Valley Hospital, Middletown, CT.
- Consulting Psychiatrist, Farrell Treatment Center, New Britain, CT; Community Faculty, University of Connecticut School of Medicine, Department of Psychiatry, Farmington, CT.
Zitieren
APA
Modesto-Lowe, V., Sgambato, D., Kaur, J., & Chaplin, M. (2026). Kratom at a crossroads: Trends, controversies, and the evidence gap. Cleveland Clinic Journal of Medicine, 93(8), 487-492. https://doi.org/10.3949/ccjm.93a.25088
Vancouver
Modesto-Lowe V, Sgambato D, Kaur J, Chaplin M. Kratom at a crossroads: Trends, controversies, and the evidence gap. Cleveland Clinic Journal of Medicine. 2026;93(8):487-492. doi:10.3949/ccjm.93a.25088
BibTeX
@article{ModestoLowe2026,
author = {Modesto-Lowe, Vania and Sgambato, Deanna and Kaur, Jasleen and Chaplin, Margaret},
title = {Kratom at a crossroads: Trends, controversies, and the evidence gap},
journal = {Cleveland Clinic Journal of Medicine},
year = {2026},
volume = {93},
number = {8},
pages = {487--492},
doi = {10.3949/ccjm.93a.25088}
}
EUVIMED